ATC code None PubChem CID 72941953 Formula C113H181N33O25S | CAS Number 926277-68-1 ChemSpider 34988374 Molar mass 2,433.945 g/mol | |
Synonyms Acetylhexa-L-lysyl-α-MSH |
Modimelanotide (INN) (code names AP-214, ABT-719, ZP-1480) is a melanocortinergic peptide drug derived from α-melanocyte-stimulating hormone (α-MSH) which was under development by, at different times, Action Pharma, Abbott Laboratories, AbbVie, and Zealand for the treatment of acute kidney injury. It acts as a non-selective melanocortin receptor agonist, with IC50 values of 2.9 nM, 1.9 nM, 3.7 nM, and 110 nM at the MC1, MC3, MC4, and MC5 receptors. Modimelanotide failed clinical trials for acute kidney injury despite showing efficacy in animal models, and development was not further pursued.
References
Modimelanotide Wikipedia(Text) CC BY-SA